George Simeon

George Simeon is listed in filings as Director at Nkarta, Inc.. This profile follows SEC Form 4 activity through Jul 17, 2025, including purchase activity. Recent filings connect the profile to Nkarta, Inc. (NKTX), Design Therapeutics, Inc. (DSGN), and CRISPR Therapeutics AG-Common Shares (CRSP). The current snapshot covers public activity from Jun 14, 2024 to Jul 17, 2025. Reported amounts are shown as $140.2K to $72.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.